These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34157950)

  • 1. Structural basis for the binding of a selective inverse agonist AF64394 with the human G-protein coupled receptor 3 (GPR3).
    Bharathi ; Roy KK
    J Biomol Struct Dyn; 2022; 40(20):10181-10190. PubMed ID: 34157950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The identification of GPR3 inverse agonist AF64394; the first small molecule inhibitor of GPR3 receptor function.
    Jensen T; Elster L; Nielsen SM; Poda SB; Loechel F; Volbracht C; Klewe IV; David L; Watson SP
    Bioorg Med Chem Lett; 2014 Nov; 24(22):5195-8. PubMed ID: 25442311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Fluorescent AF64394 Analogues Enables Real-Time Binding Studies for the Orphan Class A GPCR GPR3.
    Bresinsky M; Shahraki A; Kolb P; Pockes S; Schihada H
    J Med Chem; 2023 Nov; 66(21):15025-15041. PubMed ID: 37907069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a High-Throughput Screening-Compatible Assay for Discovery of GPR3 Inverse Agonists Using a cAMP Biosensor.
    Ayukawa K; Suzuki C; Ogasawara H; Kinoshita T; Furuno M; Suzuki G
    SLAS Discov; 2020 Mar; 25(3):287-298. PubMed ID: 31516076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPR3, GPR6, and GPR12 as novel molecular targets: their biological functions and interaction with cannabidiol.
    Laun AS; Shrader SH; Brown KJ; Song ZH
    Acta Pharmacol Sin; 2019 Mar; 40(3):300-308. PubMed ID: 29941868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPR3 and GPR6, novel molecular targets for cannabidiol.
    Laun AS; Song ZH
    Biochem Biophys Res Commun; 2017 Aug; 490(1):17-21. PubMed ID: 28571738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for the Development of In Silico GPCR Models.
    Morales P; Hurst DP; Reggio PH
    Methods Enzymol; 2017; 593():405-448. PubMed ID: 28750813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of diphenyleneiodonium analogs as GPR3 agonists.
    Gay EA; Harris DL; Wilson JW; Blough BE
    Bioorg Med Chem Lett; 2023 Oct; 94():129427. PubMed ID: 37541631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric sodium binding cavity in GPR3: a novel player in modulation of Aβ production.
    Capaldi S; Suku E; Antolini M; Di Giacobbe M; Giorgetti A; Buffelli M
    Sci Rep; 2018 Jul; 8(1):11102. PubMed ID: 30038319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel small-molecule agonist for human G protein-coupled receptor 3.
    Ye C; Zhang Z; Wang Z; Hua Q; Zhang R; Xie X
    J Pharmacol Exp Ther; 2014 Jun; 349(3):437-43. PubMed ID: 24633425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-Dependent Activation of the Orphan G Protein-Coupled Receptor, GPR3.
    Russell IC; Zhang X; Bumbak F; McNeill SM; Josephs TM; Leeming MG; Christopoulos G; Venugopal H; Flocco MM; Sexton PM; Wootten D; Belousoff MJ
    Biochemistry; 2024 Mar; 63(5):625-631. PubMed ID: 38376112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering the GPER/GPR30-agonist and antagonists interactions using molecular modeling studies, molecular dynamics, and docking simulations.
    Méndez-Luna D; Martínez-Archundia M; Maroun RC; Ceballos-Reyes G; Fragoso-Vázquez MJ; González-Juárez DE; Correa-Basurto J
    J Biomol Struct Dyn; 2015; 33(10):2161-72. PubMed ID: 25587872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Dynamics Simulations Based on 1-Phenyl-4-Benzoyl-1-Hydro-Triazole ERRα Inverse Agonists.
    Gao Z; Du Y; Sheng X; Shen J
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of an efficacy switch region in the ghrelin receptor responsible for interchange between agonism and inverse agonism.
    Holst B; Mokrosinski J; Lang M; Brandt E; Nygaard R; Frimurer TM; Beck-Sickinger AG; Schwartz TW
    J Biol Chem; 2007 May; 282(21):15799-811. PubMed ID: 17371869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards a better understanding of the cannabinoid-related orphan receptors GPR3, GPR6, and GPR12.
    Morales P; Isawi I; Reggio PH
    Drug Metab Rev; 2018 Feb; 50(1):74-93. PubMed ID: 29390908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the molecular basis of agonist/antagonist mechanism of GPER1/GPR30 through structural and energetic analyses.
    Méndez-Luna D; Bello M; Correa-Basurto J
    J Steroid Biochem Mol Biol; 2016 Apr; 158():104-116. PubMed ID: 26772481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing intermolecular interactions and binding stability of kaempferol, quercetin and resveratrol derivatives with PPAR-γ: docking, molecular dynamics and MM/GBSA approach to reveal potent PPAR- γ agonist against cancer.
    Lokhande KB; Ballav S; Yadav RS; Swamy KV; Basu S
    J Biomol Struct Dyn; 2022 Feb; 40(3):971-981. PubMed ID: 32954977
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Muthiah I; Rajendran K; Dhanaraj P; Vallinayagam S
    J Biomol Struct Dyn; 2021 Aug; 39(13):4807-4815. PubMed ID: 32580684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural complexes of the agonist, inverse agonist and antagonist bound C5a receptor: insights into pharmacology and signaling.
    Rana S; Sahoo AR; Majhi BK
    Mol Biosyst; 2016 Apr; 12(5):1586-99. PubMed ID: 26978009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.